» Articles » PMID: 39569407

Strain-level Genomic Analysis of Serotype, Genotype and Virulence Gene Composition of Group B Streptococcus

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: GBS (group B streptococcus) is an opportunistic pathogen that can colonize healthy individuals but presents significant challenges in clinical obstetrics and gynecology, as it can cause miscarriage, preterm birth, and invasive infections in newborns. To develop specific and personalized preventative strategies, a better understanding of the epidemiological characteristics and pathogenic features of GBS is essential.

Methods: We conducted a comprehensive strain-level genomic analysis of GBS, examining serotype and genotype distributions, as well as the composition and correlations of virulence genes using the blastn-short mode of the BLAST program(v2.10.0+), mlstsoftware (https://github.com/tseemann/mlst), Snippy (v4.6.0), FastTree (v2.1.11) and iTOL. The coding sequence region of virulence factors was annotated by Prodigal (v2.6.3) and Glimmer(v3.02b). We further identified host protein interacting with Srr2 by mass spectrometry analysis.

Results: While certain genotypes showed strong serotype consistency, there was no significant association between overall serotypes and genotypes. However, the composition of virulence genes was more closely related to the phylogeny of GBS, among which simultaneous presence of Srr2 and HygA exhibit significant association with hypervirulence. Tubulin emerged as the most distinct and abundant hit. The specific interaction of Tubulin with Srr2-BR, rather than Srr1-BR, was further confirmed by immunoblotting.

Discussion: Considering the impact of cytoskeleton rearrangement on GBS pathogenesis, this observation offers a plausible explanation for the hypervirulence triggered by Srr2. Collectively, our findings indicate that in the future clinical practice, virulence gene detection should be given more attention to achieve precise GBS surveillance and disease prevention.

References
1.
Jackson L, Hilsdon R, Farley M, Harrison L, Reingold A, Plikaytis B . Risk factors for group B streptococcal disease in adults. Ann Intern Med. 1995; 123(6):415-20. DOI: 10.7326/0003-4819-123-6-199509150-00003. View

2.
Kong F, Gowan S, Martin D, James G, Gilbert G . Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J Clin Microbiol. 2002; 40(2):620-6. PMC: 153396. DOI: 10.1128/JCM.40.2.620-626.2002. View

3.
Gabrielsen C, Maeland J, Lyng R, Radtke A, Afset J . Molecular characteristics of Streptococcus agalactiae strains deficient in alpha-like protein encoding genes. J Med Microbiol. 2016; 66(1):26-33. DOI: 10.1099/jmm.0.000412. View

4.
Alhhazmi A, Hurteau D, Tyrrell G . Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013. J Clin Microbiol. 2016; 54(7):1774-1781. PMC: 4922093. DOI: 10.1128/JCM.00355-16. View

5.
Baron M, Bolduc G, Goldberg M, Auperin T, Madoff L . Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J Biol Chem. 2004; 279(23):24714-23. DOI: 10.1074/jbc.M402164200. View